“Efficacy of Escitalopram (SSRI) for Better Glycemic Control in the Diabetic Depressive Patients”, Sir Salimullah Med. Coll. J., vol. 29, no. 2, pp. 100–104, Apr. 2022, doi: 10.3329/ssmcj.v29i2.58854.